|
Feb. 01, 2023 |
|
|
July. 24, 2025 |
|
|
jRCT2033220602 |
Continuous observation study after administration of ADR-001 in patients with Compensated Liver Cirrhosis |
|
ADR-001-N2 |
Terai Shuji |
||
Niigata University Medical and Dental Hospital |
||
754, Ichibancho, Asahimachidori, Chuo-ku, Niigata-shi, Niigata |
||
+81-25-227-2207 |
||
terais@med.niigata-u.ac.jp |
||
Watanabe Yusuke |
||
Niigata University Medical and Dental Hospital |
||
754, Ichibancho, Asahimachidori, Chuo-ku, Niigata-shi, Niigata |
||
+81-25-227-2207 |
||
ywatanabe19840421@med.niigata-u.ac.jp |
Complete |
Jan. 30, 2023 |
||
| Feb. 14, 2023 | ||
| 9 | ||
Observational |
||
1)Patients who received at least one dose of ADR-001 in the ADR-001-N1 Study. |
||
1)Patients decided to be ineligible for this study by the investigator. |
||
| 20age old over | ||
| No limit | ||
Both |
||
Compensated liver cirrhosis (Child-Pugh A) |
||
The amount of change in Albumin-bilirubin (ALBI) score |
||
| ROHTO Pharmaceutical Co., Ltd. | |
| Not applicable |
| Niigata University Medical and Dental Hospital IRB | |
| 754,Ichibancho,Asahimachidori,Chuo-ku,Niigata-shi., Niigata | |
+81-25-227-0901 |
|
| jimukyoku_ctrc@nuh.niigata-u.ac.jp | |
| Approval | |
Dec. 27, 2022 |
No |
none |